This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
How hybrid virtual engagement is accelerating oncology communication. Read Deep Dive: Oncology 2021 in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceuticalcompanies, biotech firms and the wider healthcare sector.
Using content metrics, companies can understand how their current content is received and engaged with, which will, in turn, helps clarify the most effective and efficient ways to connect and communicate with their audience in the future, resulting in increased speed to market and effective content engagement.
The Digital Awards is in its 12th year and celebrates the best in digital communications within the pharmaceutical and healthcare sectors. Judges include experts from digital, creative and communications agencies, digital specialists and marketers from industry as well as healthcare professionals. Pharma’s best kept secret.
The wave of interest in sustainability follows the value chain from top-tier pharmaceuticalcompanies to their suppliers of every size. About 80% of pharmaceuticalcompanies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Accessed December 7, 2021.
These are among the conclusions of a new Accenture report commissioned by the Association of the British Pharmaceutical Industry (ABPI) to establish the maturity of ED&I across its member companies. The work, carried out in September and October 2021, also found that strategies often extended beyond the workforce.
From clear communication with an unsettled, dispersed workforce to maintaining positive energy and managing people’s working hours, the need for open, inclusive and empathetic leadership has never been more important. . Available at: [link] Last accessed: November 2021. [ii] Available at: [link] Last accessed: November 2021.
People can opt out of the scheme by filling in a form and taking it to their GP, but campaigners have complained that this was not communicated effectively and could place an onerous workload on GPs already battling to provide care amid the pandemic. — Rachel Clarke (@doctor_oxford) June 8, 2021.
Pharmaceuticalcompanies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. In addition, a paper published in 2019, concluded that the pharmaceutical industry produced 48.55
.” To stay relevant, sales reps need to have accurate, up-to-date information about their audience, stand out among competitors in the crowded digital space, and make their communications more impactful. Improving the sales rep experience. “You need a profound data foundation to deliver precision engagement.
In 2021, the FDA granted Amgen’s (NASDAQ:AMGN) non-small cell lung cancer (NSCLC) drug Lumakras (sotorasib) an expedited approval, making it the first FDA-approved KRAS inhibitor. In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov.
Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceuticalcompanies of international origin within the country. by 2040 based on statistics from OECD. Free Whitepaper.
For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them. Unfortunately, this isn’t always convenient or aligned to the information and tactics they would choose to adopt in their communications. There is clear evidence of a customer-centric paradox.
The digital transformation is allowing pharmaceuticalcompanies to expand their drug discovery capabilities and accelerate drug development. The result was four innovative solutions for generating awareness about the importance of vaccines and improving vaccine access and administration.
Read on to find out using digital twins of clinical experiments could help drive progress in virtual biological models, why venture capitalists fell in love with pharma R&D in 2021, and why amplifying patient voices is vital in the rare disease space. Why VCs fell in love with pharma R&D in 2021.
This is a golden opportunity for pharmaceuticalcompanies to deploy the power of data and digital to laser-focus delivery across its client base, ultimately improving the value of engagements and capturing market share, says Treasure Data founder and CEO Kazuki Ohta. billion in 2021 to $9.23 Capturing market share.
This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceuticalcompanies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.
The most distinctive characteristic of pharma companies in APAC from pharma companies in the rest of the world is the domination in the clinical trials market. Surprisingly, nearly half of all clinical trials conducted in the world in 2021 had locations in APAC.
In July 2021, the pharmaceuticalcompany Pfizer issued a voluntary nationwide recall of Chantix (varenicline) tablets as a precautionary measure; this is due to the evidence of higher levels of nitrosamines in Chantix than what’s considered acceptable by the U.S. Most people are aware of the health benefits of stopping smoking.
A new accelerator programme has launched with the aim of improving engagement between digital health startups and pharmaceuticalcompanies, which sometimes can be held back by the different ways in which the two sectors operate.
As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. Long-term storage and delivery of vaccines are vital, especially as governments seek to vaccinate rural and remote communities.
7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 The responsibility of printing paper leaflets is currently a key regulatory obligation for pharmaceuticalcompanies.
The difficulty in gaining approval turned out to be an unexpected blessing, as one of those experts would connect the company to Hanlim, its first pharma partner. “In In early 2021, a scientific advisor who was impressed with RCI001, introduced us to several people from Hanlim,” Kim said. Moving to the global stage.
Pharmaceuticalcompany Genmab is entering a partnership with argenx to develop antibody therapies for oncology and immunology. This collaboration is being made to combine the companies’ capabilities to develop novel therapeutic antibodies with applications in the two disease areas.
In October 2021, the alliance completed pricing and reimbursement (P&R) negotiations for Zolgensma, making the gene therapy for spinal muscular atrophy available at the same price in Belgium, the Netherlands, and Ireland. Also launched in 2015, the initiative has successfully conducted several joint negotiations.
To keep within this limit, pharmaceuticalcompanies have had to pay rebates on their sales back to the NHS on all expenditures above the capped limit. Companies that choose not to take part in the voluntary scheme must partake in a statutory scheme. in 2021 to 15% in 2022, and to 26.5%
In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. These single-use technologies allow pharmaceuticalcompanies to achieve continuous manufacturing, which significantly reduces the risk of cross-contamination without the need for extensive cleaning and disinfecting.
For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. During the following decade (2010-2021), total designations more than doubled again. The stakes are high when launching an orphan drug product, however.
A collaborative mindset must prevail between pharmaceuticalcompanies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.
Of the world’s 20 largest pharmaceuticalcompanies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. Figure 1: Social media posts from pharmaceutical firms mentioning “environment”. A similar theme is evident in company filings.
Celnova Pharma is an Argentina-based pharmaceuticalcompany that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. The company currently has operations in Argentina, Colombia, Chile, Peru, and Uruguay. Free Report How is the Biopharmaceutical industry evolving?
From life-saving drugs discovery, development, and production to clinical trials, communication, and drug target identification — AI pharmaceutical is a definite game-changer. Here, we are diving deep into the main aspects of AI influence.
According to Baker Mackenzie , a law firm brand that specialises in a range of industries including healthcare and life sciences, IPOs allow pharmaceuticalcompanies to “access major global finance hubs and capital from a deep pool of investors around the world”. Free Report How is the Biopharmaceutical industry evolving?
However, now that the implementation of Regulation (EU) 2021/2282 on health technology assessment (HTA) is a reality, a constructive discussion between the industry and regulators is needed. The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028.
Biostar Pharma chairman Dr Li Tang said this study approval was a milestone in the UTD1’s global development, and expressed an interest in partnering with other pharmaceuticalcompanies to bring the treatment to market. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. ORR, 81.0%
Generic and biosimilar pharmaceuticalcompany and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Free Report How is the Biopharmaceutical industry evolving?
This latest disagreement is another chapter in the ongoing debate between regulators and pharmaceuticalcompanies over ALS trial endpoints. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. ALSFRS-R is the preferred endpoint of most clinical studies, measuring function.
Explaining the rise of HPAPIs, Bruno Villa, CEO, MEDELPHARM believes the trend is a consequence of the increasing pressure on pharmaceuticalcompanies to develop drugs with improved efficiency and efficacy. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology.
In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceuticalcompanies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Published 13 May 2021. Published September 2021.
Sixth Assessment Report: Climate Change 2021: The Physical Science Basis.” Finalized 9 August 2021. Yet if we consider these 74 companies to be representative of the entire biotechnology and pharmaceutical industry, the carbon intensity has increased by over 40% since 2015, with a marked increase over the last 2 years (2020 and 2021).
Of 2,787 small molecule API CMOs analysed by GlobalData in 2021, only a third offered containment capabilities, and only 256 facilities (9%) featured controlled substance capabilities. PAT, used correctly, should lead to better manufacturing processes and ultimately significant business benefits for the pharmaceuticalcompany.
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
9 December 2021. Increasing the Circularity of Packaging Along Pharmaceuticals Value Chain.” A pharmaceutical quality system (PQS) is a management system used to direct and control a pharmaceuticalcompany with regard to quality. The Global Use of Medicines 2022.” link] 2 Salmenperä, H., Dahlbo, and P.
ChatGPT: “In a pharmaceutical software engineering context, data integrity refers to the accuracy, consistency, and reliability of data stored in computerized systems. This is a crucial aspect of pharmaceutical software as it directly impacts patient safety.
Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Trend #1: Media and Tech: Facilitating Communication. Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content